Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Clinical trial Open access Aug 2026

Mefatinib versus gefitinib as a first-line treatment for EGFR-mutated non-small cell lung cancer: a randomized, double-blind, multicenter phase III study

Mefatinib demonstrated superior efficacy to gefitinib with a similar tolerability profile in the first-line treatment of EGFR-mutated advanced NSCLC with common and uncommon EGFR-activating mutations.

Jia Yu, Anwen Xiong, Qi-Ming Wang et al. · 0 citations
Review Open access Aug 2026

Computer Vision from Tea Cultivation to Quality Evaluation

A structured analysis of the challenges and pathways for transitioning computer vision (CV) from laboratory research toward field-deployable tools is outlined and a task-oriented algorithm selection framework for the tea industry is established.

Zunren Chen, Jin-Feng Wang, Yi-Lan Sun et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.